Chengdu Kangnuoxing Biopharma,Inc. | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis	Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitis	Recruiting	Phase 3	2026-09-03		NCT07678931
A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder	Recruiting	Not stated	2026-06-10		NCT07544862
A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)	CRSWNP	Active, not recruiting	Not stated	2026-06-05		NCT07483268
Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)	Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitis	Not yet recruiting	Phase 2	2026-06-01		NCT07617324
A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)	SAR	Not yet recruiting	Not stated	2026-03-09		NCT07459556
Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid	Skin and Connective Tissue Diseases, autoimmune disease, bullous pemphigoid, immune system disorder, skin disorder, vesiculobullous skin disease	Not yet recruiting	Phase 3	2025-10-07		NCT07210554